Successful exit for Innovation Industries: Danone acquires The Akkermansia Company
Amsterdam, 25 June 2025 – Innovation Industries, one of Europe’s leading deeptech investors, announces a successful exit of The Akkermansia Company, which has been acquired by Danone. Founded in 2016, the Akkermansia Company is based on joint research conducted at two European universities, UC Louvain and Wageningen University. Using state-of-the-art technology, scientists at The Akkermansia Company have developed a naturally occurring next-generation biotic strain, Akkermansia muciniphila MucT™, and clinically demonstrated its ability to reinforce the gut barrier and reduce immune system inflammation linked to gastrointestinal and metabolic disorders such as obesity, diabetes, and cardiovascular disease. The strategic acquisition by Danone will amplify The Akkermansia Company’s impact on global health and nutrition. Expanding deeper into gut health is a key facet of Danone’s strategy, as it doubles down on science and innovation, and as consumer interest in healthy products continues to rise.
